Literature DB >> 21614907

Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.

M Wang1, Y He, L Shi, C Shi.   

Abstract

PURPOSE OF INVESTIGATION: To evaluate the influence of various clinicopathological and biochemical factors on the survival of patients with epithelial ovarian cancer (EOC) after radical resection.
METHODS: A retrospective analysis was made for 183 cases of epithelial ovarian cancer treated from January 1997 to January 2001. Six clinicopathological factors, including menopause, histological type, histological grade, lymph node metastasis, FIGO stage and chemotherapy that could possibly influence survival were selected. The expression of COX-2 and VEGF protein as two biochemical factors were detected in EOC tissues using immunohistochemical staining. Independent variables were first analyzed by univariate methods. A multivariate analysis of these variables was performed using the Cox proportional hazard regression model.
RESULTS: The ovarian cumulative survival rate was 48.71% for three years and 30.71% for five years. Univariate analysis of overall survival involving all the patients indentified five factors that were associated with a significant outcome: menopause, histological grade, FIGO stage, COX-2 or VEGF expression level (p < 0.05). The expression of COX-2 was positive in 140 (76.5%) of these 183 cases, but was not associated with menopause, histological type, histological grade, lymph node metastasis or FIGO stage. Median survival time was 24.56 months for the patients with COX-2 positive expression, and 47.52 months for those with COX-2 negative expression (p < 0.05). VEGF protein overexpression was examined in 117 (63.93%) of all 183 cases, and was associated with lymph node metastasis (p <0.05), but not associated with menopause, histological grade, histological type or FIGO stage. The median survival time was 23.36 months for the patients with VEGF detected expression, and 42.09 months for those with no VEGF detected expression (p < 0.05). When the interactive effects of these factors were taken into account, COX-2 expression, FIGO stage, VEGF expression and histological grade were the four most important prognostic factors by multivariate analysis using the Cox proportional hazards model. Risk of death for the patients with COX-2 positive expression was 2.8 times than that with COX-2 negative expression, and for FIGO stage, VEGF expression and histological grade, risk of death was 2.2, 2.1, and 1.84 times, respectively.
CONCLUSION: COX-2 expression, FIGO stage, VEGF expression and histological grade are the most important prognostic factors for EOC after curative resection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21614907

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  9 in total

1.  Overexpression of keratin 17 is associated with poor prognosis in epithelial ovarian cancer.

Authors:  Ya-Feng Wang; Hai-Yang Lang; Jing Yuan; Jun Wang; Rui Wang; Xin-Hui Zhang; Jie Zhang; Tao Zhao; Yu-Rong Li; Jun-Ye Liu; Li-Hua Zeng; Guo-Zhen Guo
Journal:  Tumour Biol       Date:  2013-02-21

2.  Anticancer activity of NOB1-targeted shRNA combination with TRAIL in epithelial ovarian cancer cells.

Authors:  Yang Lin; Tianmin Xu; Hong Teng; Manhua Cui
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

3.  Prognostic value of centromere protein-A expression in patients with epithelial ovarian cancer.

Authors:  Jun-Jun Qiu; Jun-Jie Guo; Tian-Jiao Lv; Hong-Yan Jin; Jing-Xin Ding; Wei-Wei Feng; Ying Zhang; Ke-Qin Hua
Journal:  Tumour Biol       Date:  2013-05-28

4.  COX-2 expression in ovarian cancer: an updated meta-analysis.

Authors:  Haiming Sun; Xuelong Zhang; Donglin Sun; Xueyuan Jia; Lidan Xu; Yuandong Qiao; Yan Jin
Journal:  Oncotarget       Date:  2017-10-04

5.  Dual role of KRT17: development of papillary renal cell tumor and progression of conventional renal cell carcinoma.

Authors:  Donat Peter Sarlos; Maria V Yusenko; Lehel Peterfi; Arpad Szanto; Gyula Kovacs
Journal:  J Cancer       Date:  2019-08-28       Impact factor: 4.207

6.  Overexpression of runt-related transcription factor-2 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancer.

Authors:  Weiping Li; Shujuan Xu; Shuang Lin; Wei Zhao
Journal:  J Biomed Biotechnol       Date:  2012-10-04

7.  Non-steroid anti-inflammatory drugs, prostaglandins, and cancer.

Authors:  Viola Allaj; Changxiong Guo; Daotai Nie
Journal:  Cell Biosci       Date:  2013-02-06       Impact factor: 7.133

8.  Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer.

Authors:  Shu-Hua Zhao; Yu Wang; Li Wen; Zhen-Bo Zhai; Zhen-Hua Ai; Nian-Ling Yao; Li Wang; Wen-Chao Liu; Bi-Liang Chen; Yu Li; Hong Yang
Journal:  J Transl Med       Date:  2013-04-08       Impact factor: 5.531

9.  Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer.

Authors:  Antonio González Martín; Amit M Oza; Andrew C Embleton; Jacobus Pfisterer; Jonathan A Ledermann; Eric Pujade-Lauraine; Gunnar Kristensen; Monique A Bertrand; Philip Beale; Andrés Cervantes; Emma Kent; Richard S Kaplan; Mahesh K B Parmar; Nana Scotto; Timothy J Perren
Journal:  Gynecol Oncol       Date:  2018-11-16       Impact factor: 5.482

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.